Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial

Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial

Background: Effective treatment for Coronavirus Disease-2019 (COVID-19) is under intensive research. Nigella sativa oil (NSO) is a herbal medicine with antiviral and immunomodulatory activities, and has been recommended for the treatment of COVID-19. This study aimed to evaluate the efficacy of NSO...

Full description

Bibliographic Details
Main Authors: Abdulrahman E. Koshak, Emad A. Koshak, Abdullah F. Mobeireek, Mazen A. Badawi, Siraj O. Wali, Husam M. Malibary, Ali F. Atwah, Meshari M. Alhamdan, Reem A. Almalki, Tariq A. Madani
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Complementary Therapies in Medicine
Subjects:
COVID-19
SARS-CoV-2
Herbal medicine
Nigella sativa
Online Access:http://www.sciencedirect.com/science/article/pii/S0965229921001102

Internet

http://www.sciencedirect.com/science/article/pii/S0965229921001102

Similar Items